28 C
New Delhi
Monday, August 24, 2026

Top stocks to buy: Stock recommendations for August 24, 2026 week – check list

Published:


Top stocks to buy in week starting August 24, 2026

Stock market recommendations: Crompton Greaves, and ICICI Prudential AMC- these are the top stocks that have been picked by Motilal Oswal Wealth Management Research Desk as stock recommendations for the week starting August 24, 2026:

Stock Name CMP (Rs) Target (Rs) Upside (%)
Crompton Greaves 252 340 35%
ICICI Prudential AMC 3281 3800 16%

Crompton GreavesCROMPTON targets ~13–14% revenue CAGR through FY29 and aims to double revenue by FY31. EBITDA margin is targeted at ~11–12% by FY29 and 12%+ by FY31, with new businesses expected to contribute ~20% of revenue by FY31. CROMPTON has expanded TAM from Rs 0.8 trillion to Rs 1.6 trillion through NPD and adjacent categories such as wires, water purifiers, and solar. Product launches increased to 211 in FY26, while new-product revenue contribution rose to 17%.In 1QFY27, revenue/EBITDA/PAT grew ~12%/17%/15%, despite commodity inflation and supply disruptions. Pricing, cost savings, and operating leverage supported 40bp YoY OPM expansion to ~10%. We estimate 13%/18%/21% revenue/EBITDA/PAT CAGR over FY26-FY28.ICICI Prudential AMCICICI Prudential AMC remains a leading player in India’s mutual fund industry, with MF QAAUM of Rs 11.2 trillion and a 13.4% market share. Its equity and equity-oriented AUM stood at Rs 6.3 trillion, giving it a 14% market share. Equity QAAUM grew at a strong 33% CAGR over FY21-26, ahead of the industry’s ~29% growth.The alternatives business is emerging as an important growth driver, with QAAUM of Rs 794.5 billion, growing at ~50% CAGR over FY23-26, and contributing ~10% of operating revenue in 1Q. PMS and AIFs also offer better monetisation, with net yields of ~95bp. With alternatives expected to grow at ~20% CAGR over FY26-28, strong retail flows and customer acquisition should support earnings visibility.Growth opportunities across passives, SIFs, GIFT City and alternatives further strengthen the long-term outlook. We estimate revenue/EBITDA/PAT to grow at 14%/13%/15% CAGR over FY26-28.(Disclaimer: Recommendations and views on the stock market, or any other asset classes or personal finance management tips given by experts and analysts are their own. These opinions do not represent the views of The Times of India.)



Source link

Related articles

spot_img

Recent articles

×